Journal
TRANSPLANTATION REVIEWS
Volume 31, Issue 1, Pages 10-17Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.trre.2016.10.006
Keywords
-
Categories
Funding
- Veloxis
- Alexion
- CareDx
Ask authors/readers for more resources
Advances in immunosuppression have propelled kidney transplantation from a scientific curiosity to the optimal treatment for patients with end stage kidney disease. Declining rates of acute rejection have led to improvements in short term kidney transplant survival, culminating in incrementally better long term patient and allograft outcomes. Contextualized around established immune -suppressing drug targets, this review summarizes the history of the clinical science and highlights the pivotal trials that have led to present-day treatment standards at the level of both individual agents and multidrug regimens for kidney recipients. Finally, recently approved and emerging therapies 'are discussed, with an emphasis on challenges faced by clinicians managing this increasingly complex patient population. (C) 2016 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available